Southern Acids (M) Berhad is an investment holding company. The Company’s principal activity is the provision of management services to the subsidiary companies. Its segments include manufacturing and marketing of oleo chemical products; managing and operating of private hospital; sales of oil palm fruit and crude palm oil; warehousing and bulk conveyor operations, and others. Its core businesses include Oleochemical, Plantation and Milling, and Healthcare. The principal activities of Oleochemical business involve manufacturing and marketing of fatty acids and glycerin. In Indonesia, the Company, through its sub-subsidiaries, has over two palm oil mills with a total milling capacity of approximately 100 metric tons per hour. In Peninsular Malaysia, it has a total of over 154.9 hectares of matured area and approximately 76.1 hectares of immature area of cultivation. Its medical center, Sri Kota Specialist Medical Centre (Sri Kota) is a 232-bed tertiary private medical center in Klang.
**Do feedback to us if you see any error on the data
**Data before 2015 may not be accurate
**Dividend Yield calculated base on the last price of the year
SAB Dividend Yield Trend
SAB Quarter DY Yield
Year
Financial Year
DY_Type
Announced
EX Date
Payment Date
DY($)
Yield%
2022
31/03/2022
Final
29/07/2022
08/11/2022
28/11/2022
0.05
1.36
2021
31/03/2021
Final
29/07/2021
02/09/2021
24/09/2021
0.05
1.36
2020
31/03/2020
Final
25/08/2020
01/10/2020
23/10/2020
0.05
1.36
2019
31/03/2019
Final
31/07/2019
05/09/2019
27/09/2019
0.05
1.36
2018
31/03/2018
Final
30/07/2018
05/09/2018
28/09/2018
0.05
1.36
2017
31/03/2017
Final
28/07/2017
06/09/2017
29/09/2017
0.05
1.36
2016
31/03/2016
Final
29/07/2016
06/09/2016
30/09/2016
0.05
1.36
2015
31/03/2015
Final
05/08/2015
09/09/2015
03/10/2015
0.05
1.36
2014
31/03/2014
Final
03/09/2014
08/10/2014
31/10/2014
0.05
1.36
2013
31/03/2013
Final
02/09/2013
09/10/2013
31/10/2013
0.0575
1.56
2012
31/03/2012
Final
03/09/2012
09/10/2012
31/10/2012
0.0667
1.81
2011
31/03/2011
Final
07/09/2011
06/10/2011
28/10/2011
0.06
1.63
2010
30/04/2010
Final
04/10/2010
03/11/2010
26/11/2010
0.06
1.63
2009
30/04/2009
Final
05/10/2009
04/11/2009
26/11/2009
0.05
1.36
2008
30/04/2008
Final
03/10/2008
05/11/2008
28/11/2008
0.08
2.17
2007
30/04/2007
Final
04/10/2007
06/11/2007
29/11/2007
0.06
1.63
2006
30/04/2006
Final
04/10/2006
08/11/2006
29/11/2006
0.035
0.95
2005
30/04/2005
Final
04/10/2005
08/11/2005
29/11/2005
0.055
1.49
2004
30/04/2004
Final
06/10/2004
08/11/2004
29/11/2004
0.075
2.03
2004
30/04/2004
Special
22/10/2003
07/11/2003
29/11/2003
0.35
9.49
2003
30/04/2003
Final
03/10/2003
10/11/2003
29/11/2003
0.05
1.36
2003
30/04/2003
Interim
31/12/2002
27/01/2003
21/02/2003
0.025
0.68
2002
30/04/2002
First & Final
03/10/2002
08/11/2002
29/11/2002
0.05
1.36
2001
30/04/2001
First & Final
28/09/2001
07/11/2001
26/11/2001
0.05
1.36
SAB Annual DY Yield
Year
Annual DY($)
Frequency per yr
SpecialDY
Yield%
2022
0.05
1
No
1.36
2021
0.05
1
No
1.36
2020
0.05
1
No
1.36
2019
0.05
1
No
1.36
2018
0.05
1
No
1.36
2017
0.05
1
No
1.36
2016
0.05
1
No
1.36
2015
0.05
1
No
1.36
2014
0.05
1
No
1.36
2013
0.0575
1
No
1.56
2012
0.0667
1
No
1.81
2011
0.06
1
No
1.63
2010
0.06
1
No
1.63
2009
0.05
1
No
1.36
2008
0.08
1
No
2.17
2007
0.06
1
No
1.63
2006
0.035
1
No
0.95
2005
0.055
1
No
1.49
2004
0.425
2
Yes
11.52
2003
0.075
2
No
2.03
2002
0.05
1
No
1.36
2001
0.05
1
No
1.36
SAB Quarter Report History
Q Date
Announced
Revenue
P/L
EPS
Margin
QoQ%
YoY%
31/12/2022
24/02/2023
275,860,000
16,790,000.00
12.26
6.09
50.45
-38.16
30/09/2022
24/11/2022
280,050,000
11,160,000.00
8.15
3.99
-24.85
-34.89
30/06/2022
29/08/2022
297,000,000
14,850,000.00
10.84
5.00
-44.34
-36.75
31/03/2022
19/05/2022
364,420,000
26,680,000.00
19.48
7.32
-1.73
313.00
31/12/2021
25/02/2022
307,160,000
27,150,000.00
19.83
8.84
58.40
386.56
30/09/2021
25/11/2021
246,710,000
17,140,000.00
12.52
6.95
-27.00
110.31
30/06/2021
21/09/2021
257,960,000
23,480,000.00
17.15
9.10
263.47
36.83
31/03/2021
25/05/2021
222,450,000
6,460,000.00
4.72
2.90
15.77
-22.26
31/12/2020
25/02/2021
185,640,000
5,580,000.00
4.07
3.01
-31.53
-46.50
30/09/2020
26/11/2020
174,660,000
8,150,000.00
5.96
4.67
-52.51
5.98
SAB Quarter Profit Trend
SAB Annual Profit Trend
Cash Flow
In financial accounting, operating cash flow (OCF), cash flow provided by operations, cash flow from operating activities (CFO) or free cash flow from operations (FCFO), refers to the amount of cash a company generates from the revenues it brings in, excluding costs associated with long – term investment on capital items or investment in securities.(From Wiki)
SAB Annual Cash Flow
ROE & Payout Ratio
Return on equity (ROE) is a measure of financial performance calculated by dividing net income by shareholders’ equity. Because shareholders’ equity is equal to a company’s assets minus its debt, ROE is considered the return on net assets. ROE is considered a measure of the profitability of a corporation in relation to stockholders’ equity. (From Investopedia)
The payout ratio is a financial metric showing the proportion of earnings a company pays its shareholders in the form of dividends, expressed as a percentage of the company’s total earnings. On some occasions, the payout ratio refers to the dividends paid out as a percentage of a company’s cash flow. The payout ratio is also known as the dividend payout ratio. (From Investopedia)
SAB Annual ROE & Payout Ratio
0 Comments
Southern Acids (M) Bhd is an investment holding and the provision of management service company. The company’s operating segment includes Oleochemical; Healthcare; Milling and Estate and Investments and services. It generates maximum revenue from the Oleochemical segment. The Oleochemical Segment is involved in the manufacturing and marketing of fatty acids and glycerine. Its Milling and Estate Segment is principally engaged in the processing of Fresh Fruit Bunches. Geographically, it has a presence in Malaysia, Indonesia, Europe, America, and Other Countries.
Southern Acids (M) Bhd is an investment holding and the provision of management service company. The company’s operating segment includes Oleochemical; Healthcare; Milling and Estate and Investments and services. It generates maximum revenue from the Oleochemical segment. The Oleochemical Segment is involved in the manufacturing and marketing of fatty acids and glycerine. Its Milling and Estate Segment is principally engaged in the processing of Fresh Fruit Bunches. Geographically, it has a presence in Malaysia, Indonesia, Europe, America, and Other Countries.